Banque Cantonale Vaudoise Biomarin Pharmaceutical Inc Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 16,000 shares of BMRN stock, worth $1.11 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,000

Previous 16,350 2.14%

Holding current value

$1.11 Million

Previous $1.35 Million 16.42%

% of portfolio

0.05%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$69.02 - $93.84 $24,157 - $32,844	-350 Reduced 2.14%	16,000 $1.13 Million
Q1 2024 Apr 10, 2024	SELL	$83.81 - $99.0 $34,697 - $40,986	-414 Reduced 2.47%	16,350 $1.43 Million
Q4 2023 Feb 07, 2024	SELL	$76.22 - $98.51 $218,751 - $282,723	-2,870 Reduced 14.62%	16,764 $1.62 Million
Q3 2023 Nov 08, 2023	SELL	$85.07 - $94.48 $45,597 - $50,641	-536 Reduced 2.66%	19,634 $1.74 Million
Q2 2023 Aug 09, 2023	SELL	$86.68 - $100.3 $4,334 - $5,015	-50 Reduced 0.25%	20,170 $1.75 Million
Q1 2023 Apr 20, 2023	SELL	$87.74 - $117.27 $333,412 - $445,626	-3,800 Reduced 15.82%	20,220 $1.97 Million
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $302,840 - $406,493	3,742 Added 18.45%	24,020 $2.49 Million
Q3 2022 Oct 17, 2022	BUY	$82.16 - $96.94 $42,887 - $50,602	522 Added 2.64%	20,278 $1.72 Million
Q2 2022 Aug 02, 2022	SELL	$71.48 - $86.85 $50,036 - $60,794	-700 Reduced 3.42%	19,756 $1.64 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $68,994 - $87,994	-962 Reduced 4.49%	20,456 $1.81 Million
Q3 2021 Oct 29, 2021	BUY	$74.77 - $85.47 $1.16 Million - $1.32 Million	15,500 Added 261.91%	21,418 $1.66 Million
Q2 2021 Aug 11, 2021	SELL	$75.51 - $84.79 $182,356 - $204,767	-2,415 Reduced 28.98%	5,918 $494,000
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $431,789 - $524,006	-5,778 Reduced 40.95%	8,333 $628,000
Q4 2020 Feb 05, 2021	BUY	$72.61 - $90.2 $102,670 - $127,542	1,414 Added 11.14%	14,111 $1.24 Million
Q3 2020 Oct 30, 2020	SELL	$71.87 - $131.03 $148,339 - $270,445	-2,064 Reduced 13.98%	12,697 $965,000
Q2 2020 Jul 22, 2020	BUY	$79.55 - $124.22 $601,159 - $938,730	7,557 Added 104.9%	14,761 $1.82 Million
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $29,689 - $40,289	-416 Reduced 5.46%	7,204 $608,000
Q4 2019 Feb 10, 2020	BUY	$64.27 - $86.37 $489,737 - $658,139	7,620 New	7,620 $644,000

Others Institutions Holding BMRN

# of Institutions

628

Shares Held

183M

Call Options Held

Put Options Held

1.67M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.9B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Biomarin Pharmaceutical Inc Transaction History